A combined approach with whole genome sequencing and artificial intelligence, towards combating antimicrobial resistance in tuberculosis, by generating a comprehensive drug susceptibility report for individual patients, a 100X faster than existing solutions.
Benefits
There is a dearth of tools in the market that can provide a rapid and comprehensive diagnosis of drug-resistant tuberculosis. Hence, AarogyaAI®’s algorithm is extremely relevant as it provides a comprehensive precision drug susceptibility report for the patients, based on the genome of the M. tb infecting the patient.
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.
AarogyaAI Innovations Private Limited:, Bangalore, Karnataka
Accessibility Controls